Boxer Capital, LLC
- SEC CIK
- 0001465837
- Latest filing
- Feb 14, 2025
Holdings in Q3 2023
Holdings as of Sep 30, 2023, filed Nov 14, 2023. Long positions only; changes compare share counts with Q2 2023.
- Positions
- 73
- −6 vs. Q2 2023
- Portfolio value
- $1.88B
- −$277.7M (−12.9%) vs. Q2 2023
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| MRTXMirati Therapeutics, Inc. | COM | 3,201,440 | $139.5M | 7.4% | +1,201,440+60.1% | Added | History |
| RVMDRevolution Medicines, Inc. | COM | 4,684,264 | $129.7M | 6.9% | 00.0% | Unchanged | History |
| ONCBeOne Medicines Ltd. | ADR | 500,000 | $89.9M | 4.8% | 00.0% | Unchanged | History |
| TYRATyra Biosciences, Inc. | COM | 6,448,359 | $88.8M | 4.7% | 00.0% | Unchanged | History |
| AKROAkero Therapeutics, Inc. | COM | 1,676,733 | $84.8M | 4.5% | 00.0% | Unchanged | History |
| TNGXTango Therapeutics, Inc. | COM | 7,123,642 | $80.2M | 4.3% | 00.0% | Unchanged | History |
| SWTXSpringWorks Therapeutics, Inc. | COM | 3,421,541 | $79.1M | 4.2% | 00.0% | Unchanged | History |
| SRPTSarepta Therapeutics, Inc. | COM | 600,000 | $72.7M | 3.9% | 00.0% | Unchanged | History |
| APLSApellis Pharmaceuticals, Inc. | COM | 1,726,000 | $65.7M | 3.5% | +150,000+9.5% | Added | History |
| CYTKCytokinetics Inc | COM NEW | 2,100,000 | $61.9M | 3.3% | 00.0% | Unchanged | History |
| IDYAIDEAYA Biosciences, Inc. | COM | 2,202,812 | $59.4M | 3.2% | 00.0% | Unchanged | History |
| NUVLNuvalent, Inc. | COM | 1,210,192 | $55.6M | 3.0% | 00.0% | Unchanged | History |
| IMGNImmunoGen, Inc. | COM | 2,961,000 | $47.0M | 2.5% | 00.0% | Unchanged | History |
| MRUSMerus N.V. | COM | 1,900,000 | $44.8M | 2.4% | 00.0% | Unchanged | History |
| KRTXKaruna Therapeutics, Inc. | COM | 250,000 | $42.3M | 2.3% | 00.0% | Unchanged | History |
| ARGXArgenx SE | SPONSORED ADR | 85,000 | $41.8M | 2.2% | +10,000+13.3% | Added | History |
| LEGNLegend Biotech Corp | SPONSORED ADS | 600,000 | $40.3M | 2.1% | 00.0% | Unchanged | History |
| AMLXAmylyx Pharmaceuticals, Inc. | COM | 2,084,000 | $38.2M | 2.0% | 00.0% | Unchanged | History |
| State Street SPDR S&P Biotech ETF78464A870 | ETF | 500,000 | $36.5M | 1.9% | +500,000 | New | – |
| PRTAProthena Corp Public Ltd Co | SHS | 625,000 | $30.2M | 1.6% | +325,000+108.3% | Added | History |
| RCKTRocket Pharmaceuticals, Inc. | COM | 1,466,051 | $30.0M | 1.6% | 00.0% | Unchanged | History |
| VTYXVentyx Biosciences, Inc. | COM | 850,000 | $29.5M | 1.6% | 00.0% | Unchanged | History |
| IMVTImmunovant, Inc. | COM | 750,000 | $28.8M | 1.5% | +750,000 | New | History |
| RCUSArcus Biosciences, Inc. | COM | 1,602,200 | $28.8M | 1.5% | 00.0% | Unchanged | History |
| FOLDAmicus Therapeutics, Inc. | COM | 2,325,000 | $28.3M | 1.5% | 00.0% | Unchanged | History |
| AXSMAxsome Therapeutics, Inc. | COM | 400,000 | $28.0M | 1.5% | 00.0% | Unchanged | History |
| EXELExelixis, Inc. | COM | 1,150,000 | $25.1M | 1.3% | 00.0% | Unchanged | History |
| ANABAnaptysbio, Inc | COM | 1,300,000 | $23.3M | 1.2% | 00.0% | Unchanged | History |
| SAGESage Therapeutics, Inc. | COM | 1,094,000 | $22.5M | 1.2% | 00.0% | Unchanged | History |
| VKTXViking Therapeutics, Inc. | COM | 2,000,000 | $22.1M | 1.2% | 00.0% | Unchanged | History |
| XENEXenon Pharmaceuticals Inc. | COM | 600,000 | $20.5M | 1.1% | 00.0% | Unchanged | History |
| ITOSiTeos Therapeutics, Inc. | COM | 1,804,058 | $19.8M | 1.1% | −350,000−16.2% | Reduced | History |
| PMVPPMV Pharmaceuticals, Inc. | COM | 3,163,795 | $19.4M | 1.0% | 00.0% | Unchanged | History |
| IOVAIovance Biotherapeutics, Inc. | COM | 3,705,133 | $16.9M | 0.9% | 00.0% | Unchanged | History |
| PNTPOINT Biopharma Global Inc. | COM | 2,500,000 | $16.7M | 0.9% | 00.0% | Unchanged | History |
| KALVKalVista Pharmaceuticals, Inc. | COM | 1,650,000 | $15.9M | 0.8% | 00.0% | Unchanged | History |
| RLAYRelay Therapeutics, Inc. | COM | 1,819,132 | $15.3M | 0.8% | 00.0% | Unchanged | History |
| MDGLMadrigal Pharmaceuticals, Inc. | COM | 100,000 | $14.6M | 0.8% | 00.0% | Unchanged | History |
| DAWNDay One Biopharmaceuticals, Inc. | Stock | 1,189,943 | $14.6M | 0.8% | 00.0% | Unchanged | History |
| ORICOric Pharmaceuticals, Inc. | COM | 1,732,571 | $10.5M | 0.6% | 00.0% | Unchanged | History |
| CGEMCullinan Therapeutics, Inc. | COM | 1,074,082 | $9.72M | 0.5% | 00.0% | Unchanged | History |
| NRIXNurix Therapeutics, Inc. | COM | 1,224,892 | $9.63M | 0.5% | 00.0% | Unchanged | History |
| ABOSAcumen Pharmaceuticals, Inc. | COM | 2,206,983 | $9.16M | 0.5% | +2,206,983 | New | History |
| ZNTLZentalis Pharmaceuticals, Inc. | COM | 450,000 | $9.03M | 0.5% | 00.0% | Unchanged | History |
| ASNDAscendis Pharma A/S | SPONSORED ADR | 95,000 | $8.90M | 0.5% | 00.0% | Unchanged | History |
| ELVNEnliven Therapeutics, Inc. | COM | 646,058 | $8.83M | 0.5% | −64,586−9.1% | Reduced | History |
| PRLDPrelude Therapeutics Inc | COM | 2,495,018 | $7.71M | 0.4% | 00.0% | Unchanged | History |
| Avidity Biosciences, Inc.05370A108 | COM | 1,121,327 | $7.15M | 0.4% | 00.0% | Unchanged | – |
| GERNGeron Corp | COM | 3,000,000 | $6.36M | 0.3% | 00.0% | Unchanged | History |
| GOSSGossamer Bio, Inc. | COM | 6,497,700 | $5.41M | 0.3% | +3,160,772+94.7% | Added | History |
| COGTCogent Biosciences, Inc. | COM | 525,000 | $5.12M | 0.3% | 00.0% | Unchanged | History |
| CNTACentessa Pharmaceuticals plc | SPONSORED ADS | 770,708 | $4.99M | 0.3% | −480,429−38.4% | Reduced | History |
| RAPTRAPT Therapeutics, Inc. | COM | 300,000 | $4.99M | 0.3% | 00.0% | Unchanged | History |
| THRDThird Harmonic Bio, Inc. | COM | 520,417 | $3.33M | 0.2% | −50,000−8.8% | Reduced | History |
| MRSNMersana Therapeutics, Inc. | COM | 2,000,000 | $2.54M | 0.1% | +1,000,000+100.0% | Added | History |
| EQRXEQRx, Inc. | COM | 1,000,000 | $2.22M | 0.1% | 00.0% | Unchanged | History |
| OBIOOrchestra BioMed Holdings, Inc. | COM | 238,193 | $2.08M | 0.1% | −11,807−4.7% | Reduced | History |
| TSVT2seventy bio, Inc. | COMMON STOCK | 459,836 | $1.80M | 0.1% | 00.0% | Unchanged | History |
| BDTXBlack Diamond Therapeutics, Inc. | COM | 506,000 | $1.45M | 0.1% | −1,508,858−74.9% | Reduced | History |
| DBVTDBV Technologies S.A. | SPONSORED ADR | 985,100 | $1.34M | 0.1% | −464,900−32.1% | Reduced | History |
| BCABBioAtla, Inc. | COM | 686,347 | $1.17M | 0.1% | 00.0% | Unchanged | History |
| KODKodiak Sciences Inc. | COM | 600,000 | $1.08M | 0.1% | +600,000 | New | History |
| FATEFate Therapeutics Inc | COM | 500,000 | $1.06M | 0.1% | 00.0% | Unchanged | History |
| Rain Oncology Inc.75082Q105 | COM | 1,152,212 | $993.0K | 0.1% | 00.0% | Unchanged | – |
| MISTMilestone Pharmaceuticals Inc. | COM | 309,007 | $957.9K | 0.1% | −389,854−55.8% | Reduced | History |
| VRCAVerrica Pharmaceuticals Inc. | COM | 166,955 | $648.6K | <0.1% | +166,955 | New | History |
| BCELAtreca, Inc. | CL A COM | 2,202,333 | $574.8K | <0.1% | 00.0% | Unchanged | History |
| NGMNGM Biopharmaceuticals Inc | COM | 500,000 | $535.0K | <0.1% | 00.0% | Unchanged | History |
| THRXTheseus Pharmaceuticals, Inc. | COM | 150,000 | $403.5K | <0.1% | −200,000−57.1% | Reduced | History |
| TARAProtara Therapeutics, Inc. | COM STK | 209,227 | $349.4K | <0.1% | 00.0% | Unchanged | History |
| TCRTAlaunos Therapeutics, Inc. | COM | 1,100,000 | $145.0K | <0.1% | −400,000−26.7% | Reduced | History |
| Nuvation Bio Inc.67080N119 | *W EXP 07/07/202 | 266,666 | $26.7K | <0.1% | 00.0% | Unchanged | – |
| Surrozen, Inc.86889P117 | *W EXP 08/01/203 | 66,666 | $2.75K | <0.1% | 00.0% | Unchanged | – |
Sold out since Q2 2023 (11)
Positions held at the end of Q2 2023 that are gone from this filing.
| Security | Class | Shares in Q2 2023 | Value in Q2 2023 | % of portfolio in Q2 2023 | History |
|---|---|---|---|---|---|
| RETAReata Pharmaceuticals Inc | CL A | 1,430,004 | $145.8M | 6.8% | History |
| ETNB89bio, Inc. | COM | 2,100,000 | $39.8M | 1.8% | History |
| ISEEIVERIC bio, Inc. | COM | 825,000 | $32.5M | 1.5% | History |
| CABACabaletta Bio, Inc. | COM | 540,000 | $6.97M | 0.3% | History |
| IRONDisc Medicine, Inc. | COM | 130,000 | $5.77M | 0.3% | History |
| RNACCartesian Therapeutics, Inc. | COM | 3,284,072 | $3.68M | 0.2% | History |
| MREOMereo BioPharma Group plc | SPON ADS | 2,250,000 | $2.97M | 0.1% | History |
| KNTEKinnate Biopharma Inc. | COM | 491,000 | $1.49M | 0.1% | History |
| LITSLite Strategy, Inc. | COM NEW | 145,654 | $958.0K | <0.1% | History |
| VERUVeru Inc. | COM | 347,300 | $413.0K | <0.1% | History |
| Bellicum Pharmaceuticals, Inc079481404 | COM NEW | 450,000 | $167.0K | <0.1% | – |